PBYI Insider Trading

Insider Ownership Percentage: 23.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $667,379.98

Puma Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at Puma Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Puma Biotechnology Share Price & Price History

Current Price: $2.75
Price Change: Price Decrease of -0.03 (-1.08%)
As of 12/20/2024 06:31 PM ET

This chart shows the closing price history over time for PBYI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Puma Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/12/2024Michael Patrick MillerDirectorSell23,358$3.49$81,519.4247,000View SEC Filing Icon  
7/17/2024Alan H. AuerbachCEOSell21,920$3.70$81,104.007,063,515View SEC Filing Icon  
7/17/2024Jeffrey Jerome LudwigInsiderSell2,598$3.70$9,612.60118,388View SEC Filing Icon  
7/17/2024Maximo F. NouguesCFOSell4,156$3.70$15,377.20162,522View SEC Filing Icon  
7/2/2024Alan H. AuerbachCEOSell18,885$3.27$61,753.957,085,435View SEC Filing Icon  
7/2/2024Jeffrey Jerome LudwigInsiderSell6,051$3.27$19,786.77120,986View SEC Filing Icon  
7/2/2024Maximo F. NouguesCFOSell5,295$3.27$17,314.65166,678View SEC Filing Icon  
6/13/2024Troy Edward WilsonDirectorSell27,000$3.33$89,910.00350View SEC Filing Icon  
1/3/2024Alan H. AuerbachCEOSell41,396$4.49$185,868.046,936,947View SEC Filing Icon  
1/3/2024Alvin F. WongInsiderSell7,733$4.49$34,721.1798,214View SEC Filing Icon  
1/3/2024Maximo F. NouguesCFOSell15,682$4.49$70,412.18128,666View SEC Filing Icon  
11/7/2023Michael Patrick MillerDirectorSell25,000$2.83$70,750.0043,358View SEC Filing Icon  
7/3/2023Alan H. AuerbachCEOSell60,698$3.31$200,910.386,978,343View SEC Filing Icon  
7/3/2023Alvin F. WongInsiderSell6,938$3.31$22,964.78105,947View SEC Filing Icon  
7/3/2023Maximo F. NouguesCFOSell14,680$3.31$48,590.80144,348View SEC Filing Icon  
6/13/2023Troy Edward WilsonDirectorSell27,000$3.45$93,150.00350View SEC Filing Icon  
6/2/2023Alvin F. WongInsiderSell269$3.45$928.05112,885View SEC Filing Icon  
1/3/2023Alan H. AuerbachCEOSell27,241$4.18$113,867.386,852,638View SEC Filing Icon  
1/3/2023Alvin F. WongInsiderSell3,460$4.18$14,462.8054,553View SEC Filing Icon  
1/3/2023Maximo F. NouguesCFOSell10,499$4.18$43,885.82100,427View SEC Filing Icon  
11/2/2022Alan H. AuerbachCEOSell1,242$2.25$2,794.506,312,949View SEC Filing Icon  
11/2/2022Douglas M. HuntInsiderSell429$2.25$965.2576,004View SEC Filing Icon  
11/2/2022Maximo F. NouguesCFOSell163$2.25$366.75111,085View SEC Filing Icon  
10/3/2022Alan H. AuerbachCEOSell1,260$2.34$2,948.406,314,191View SEC Filing Icon  
10/3/2022Douglas M. HuntInsiderSell435$2.34$1,017.9076,433View SEC Filing Icon  
10/3/2022Maximo F. NouguesCFOSell165$2.34$386.10111,248View SEC Filing Icon  
8/9/2022Michael Patrick MillerDirectorSell25,000$3.55$88,750.0054,858View SEC Filing Icon  
8/2/2022Alan H. AuerbachCEOSell1,247$2.89$3,603.836,316,705View SEC Filing Icon  
8/2/2022Douglas M. HuntInsiderSell429$2.89$1,239.8177,301View SEC Filing Icon  
8/2/2022Maximo F. NouguesCFOSell161$2.89$465.29111,577View SEC Filing Icon  
7/5/2022Alan H. AuerbachCEOSell26,140$2.63$68,748.206,317,952View SEC Filing Icon  
7/5/2022Douglas M. HuntInsiderSell3,753$2.63$9,870.3977,730View SEC Filing Icon  
7/5/2022Maximo F. NouguesCFOSell5,835$2.63$15,346.0564,625View SEC Filing Icon  
6/16/2022Troy Edward WilsonDirectorSell27,858$2.58$71,873.6427,350View SEC Filing Icon  
6/2/2022Alan H. AuerbachCEOSell1,200$1.94$2,328.006,344,092View SEC Filing Icon  
6/2/2022Alvin F. WongInsiderSell587$1.92$1,127.0461,447View SEC Filing Icon  
6/2/2022Maximo F. NouguesCFOSell162$1.92$311.04121,066View SEC Filing Icon  
5/3/2022Alan H. AuerbachCEOSell1,263$2.32$2,930.166,345,292View SEC Filing Icon  
5/3/2022Douglas M. HuntInsiderSell438$2.31$1,011.7881,900View SEC Filing Icon  
5/3/2022Maximo F. NouguesCFOSell165$2.34$386.10121,228View SEC Filing Icon  
4/4/2022Alan H. AuerbachCEOSell1,198$3.08$3,689.846,346,555View SEC Filing Icon  
3/2/2022Alan H. AuerbachCEOSell1,294$2.26$2,924.44View SEC Filing Icon  
3/2/2022Douglas M. HuntInsiderSell446$2.26$1,007.96View SEC Filing Icon  
3/2/2022Maximo F. NouguesCFOSell169$2.26$381.94View SEC Filing Icon  
2/2/2022Alan H. AuerbachCEOSell1,316$2.46$3,237.36View SEC Filing Icon  
2/2/2022Douglas M. HuntInsiderSell533$2.47$1,316.51View SEC Filing Icon  
2/2/2022Maximo F. NouguesCFOSell199$2.48$493.52View SEC Filing Icon  
1/3/2022Alan H. AuerbachCEOSell22,875$3.19$72,971.25View SEC Filing Icon  
1/3/2022Douglas M. HuntInsiderSell3,707$3.21$11,899.47View SEC Filing Icon  
1/3/2022Maximo F. NouguesCFOSell7,484$3.19$23,873.96View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Puma Biotechnology (NASDAQ:PBYI)

61.29% of Puma Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PBYI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Puma Biotechnology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024Franklin Resources Inc.15,967$41K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/20/2024Virtu Financial LLC26,509$68K0.0%N/A0.054%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC78,021$0.20M0.0%+146.5%0.159%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC917,367$2.34M0.0%-3.4%1.869%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC78,021$0.20M0.0%+146.5%0.159%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd26,384$67K0.0%-45.7%0.054%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC32,129$82K0.0%+103.9%0.065%Search for SEC Filing on Google Icon
11/15/2024State Street Corp601,542$1.53M0.0%+17.0%1.225%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets67,702$0.17M0.0%+2,002.5%0.138%Search for SEC Filing on Google Icon
11/13/2024FMR LLC118,265$0.30M0.0%+27.1%0.241%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP108,129$0.28M0.1%N/A0.220%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd17,366$44K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.117,666$0.30M0.0%-6.8%0.240%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.368,455$0.94M0.0%+3.9%0.751%Search for SEC Filing on Google Icon
11/8/2024Prospera Financial Services Inc168,885$0.43M0.0%+12.9%0.344%Search for SEC Filing on Google Icon
11/6/2024Royce & Associates LP20,165$51K0.0%+71.8%0.041%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.35,097$89K0.0%+111.9%0.072%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP49,494$0.13M0.0%-73.9%0.101%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC245,695$0.63M0.0%N/A0.501%Search for SEC Filing on Google Icon
10/24/2024Patriot Financial Group Insurance Agency LLC19,000$48K0.0%+72.7%0.039%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC13,416$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/16/2024Frazier Life Sciences Management L.P.3,062,558$9.98M0.5%+8.7%6.349%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company17,765$58K0.0%N/A0.036%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC3,162,533$10.31M0.0%-4.0%6.448%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC250,000$0.82M0.1%N/A0.510%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC71,391$0.23M0.0%+17.7%0.146%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC1,486,544$4.85M0.9%+10.6%3.082%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP200,085$0.65M0.0%-16.1%0.415%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd48,611$0.16M0.0%-10.2%0.101%Search for SEC Filing on Google Icon
8/12/2024Marathon Trading Investment Management LLC14,236$46K0.0%-79.7%0.030%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC1,753,013$5.72M0.0%+1.4%3.634%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP605,977$1.98M0.0%+6.6%1.256%Search for SEC Filing on Google Icon
8/9/2024WINTON GROUP Ltd300,599$0.98M0.1%+59.7%0.623%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.738,902$2.41M0.0%+98.5%1.532%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC144,792$0.47M0.0%+3.3%0.300%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC1,951,208$6.36M0.0%-0.3%4.045%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.16,565$54K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers50,270$0.16M0.0%+2,309.9%0.104%Search for SEC Filing on Google Icon
8/1/2024Ritholtz Wealth Management33,759$0.11M0.0%-9.6%0.070%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.102,820$0.34M0.0%N/A0.213%Search for SEC Filing on Google Icon
7/26/2024Patriot Financial Group Insurance Agency LLC11,000$36K0.0%-37.5%0.023%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp308,997$1.01M0.0%+63.6%0.641%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.140,205$0.46M0.0%+99.9%0.291%Search for SEC Filing on Google Icon
5/17/2024Athyrium Capital Management LP1,256,411$6.66M9.1%-29.9%2.605%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC49,466$0.26M0.0%+5,129.0%0.103%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC61,991$0.33M0.3%N/A0.129%Search for SEC Filing on Google Icon
5/13/2024O Shaughnessy Asset Management LLC77,081$0.41M0.0%+127.7%0.160%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC1,956,513$10.37M0.0%+2.0%4.056%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.3,491,249$18.50M0.0%-8.2%7.237%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.289,677$1.54M0.0%-0.8%0.600%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC10,740$57K0.0%N/A0.022%Search for SEC Filing on Google Icon
5/6/2024LSV Asset Management30,400$0.16M0.0%-64.9%0.063%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP187,585$0.99M0.1%-28.5%0.389%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.70,145$0.37M0.0%-17.5%0.145%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC140,106$0.74M0.0%-57.5%0.291%Search for SEC Filing on Google Icon
2/15/2024Great Point Partners LLC1,093,273$4.73M0.8%N/A2.298%Search for SEC Filing on Google Icon
2/12/2024Crestline Management LP34,774$0.15M0.0%+6.5%0.073%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC57,200$0.25M0.0%+131.7%0.120%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.161,540$0.70M0.0%-11.2%0.340%Search for SEC Filing on Google Icon
1/18/2024Ritholtz Wealth Management15,178$66K0.0%N/A0.032%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.85,039$0.37M0.0%+23.0%0.179%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.99,767$0.26M0.0%N/A0.210%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP279,629$0.74M0.1%+143.8%0.588%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC1,858,000$4.88M0.0%-0.9%3.906%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC24,690$65K0.0%+26.6%0.052%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.69,142$0.18M0.0%-69.0%0.146%Search for SEC Filing on Google Icon
11/4/2023LSV Asset Management86,651$0.23M0.0%-55.5%0.182%Search for SEC Filing on Google Icon
11/2/2023Rice Hall James & Associates LLC363,666$0.96M0.1%-2.0%0.765%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp52,923$0.14M0.0%-26.8%0.111%Search for SEC Filing on Google Icon
10/19/2023Patriot Financial Group Insurance Agency LLC67,000$0.18M0.0%-7.8%0.141%Search for SEC Filing on Google Icon
8/21/2023Affinity Asset Advisors LLC202,349$0.71M0.2%+14.1%0.426%Search for SEC Filing on Google Icon
8/8/2023Prospera Financial Services Inc108,448$0.38M0.0%+8.4%0.232%Search for SEC Filing on Google Icon
7/25/2023Assenagon Asset Management S.A.223,321$0.79M0.0%+15.6%0.478%Search for SEC Filing on Google Icon
7/24/2023Rice Hall James & Associates LLC371,034$1.31M0.1%+1.0%0.794%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC177,349$0.55M0.2%N/A0.380%Search for SEC Filing on Google Icon
5/12/2023Rice Hall James & Associates LLC367,497$1.14M0.1%-4.1%0.787%Search for SEC Filing on Google Icon
5/11/2023Acadian Asset Management LLC1,874,859$5.79M0.0%+3.4%4.014%Search for SEC Filing on Google Icon
5/11/2023Cornercap Investment Counsel Inc.124,919$0.39M0.1%N/A0.267%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.191,063$0.59M0.0%-45.5%0.409%Search for SEC Filing on Google Icon
5/8/2023Bailard Inc.14,102$44K0.0%-73.6%0.030%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC34,900$0.11M0.0%-25.5%0.075%Search for SEC Filing on Google Icon
5/2/2023LSV Asset Management194,551$0.60M0.0%-3.3%0.417%Search for SEC Filing on Google Icon
4/20/2023Patriot Financial Group Insurance Agency LLC36,000$0.11M0.0%+26.3%0.077%Search for SEC Filing on Google Icon
4/18/2023Assenagon Asset Management S.A.193,194$0.60M0.0%+16.3%0.414%Search for SEC Filing on Google Icon
3/28/2023Acrisure Capital Management LLC25,409$0.11M0.1%N/A0.054%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC36,500$0.15M0.0%N/A0.080%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP72,940$0.31M0.0%-48.0%0.160%Search for SEC Filing on Google Icon
2/10/2023Globeflex Capital L P561,530$2.38M0.3%-1.6%1.230%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.183,270$0.78M0.0%+22.8%0.402%Search for SEC Filing on Google Icon
2/8/2023LSV Asset Management201,151$0.85M0.0%+10.5%0.441%Search for SEC Filing on Google Icon
2/8/2023Prospera Financial Services Inc88,322$0.37M0.0%+7.4%0.194%Search for SEC Filing on Google Icon
2/7/2023AlphaCentric Advisors LLC50,000$0.21M0.2%-88.0%0.110%Search for SEC Filing on Google Icon
2/7/2023Commonwealth Equity Services LLC10,859$45K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can32,265$0.15M0.0%N/A0.071%Search for SEC Filing on Google Icon
1/27/2023Rice Hall James & Associates LLC383,218$1.62M0.1%-1.1%0.840%Search for SEC Filing on Google Icon
1/17/2023Patriot Financial Group Insurance Agency LLC28,500$0.12M0.0%-43.6%0.062%Search for SEC Filing on Google Icon
11/15/2022Kynam Capital Management LP559,769$1.33M0.3%-3.5%1.226%Search for SEC Filing on Google Icon
11/15/2022Brandywine Global Investment Management LLC318,601$0.76M0.0%-3.6%0.698%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC1,000,000$2.37M0.0%-33.3%2.191%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC1,799,662$4.27M0.0%-9.0%3.943%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Puma Biotechnology logo
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Read More on Puma Biotechnology

Today's Range

Now: $2.75
Low: $2.74
High: $2.89

50 Day Range

MA: $2.95
Low: $2.42
High: $3.39

52 Week Range

Now: $2.75
Low: $2.22
High: $7.73

Volume

360,487 shs

Average Volume

463,782 shs

Market Capitalization

$134.99 million

P/E Ratio

5.73

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Puma Biotechnology?

Puma Biotechnology's top insider shareholders include:
  1. Alan H Auerbach (CEO)
  2. Maximo F Nougues (CFO)
  3. Jeffrey Jerome Ludwig (Insider)
  4. Alvin F Wong (Insider)
  5. Michael Patrick Miller (Director)
  6. Troy Edward Wilson (Director)
Learn More about top insider investors at Puma Biotechnology.

Who are the major institutional investors of Puma Biotechnology?

Puma Biotechnology's top institutional investors include:
  1. Geode Capital Management LLC — 1.87%
  2. State Street Corp — 1.23%
  3. Connor Clark & Lunn Investment Management Ltd. — 0.75%
  4. Los Angeles Capital Management LLC — 0.50%
  5. Prospera Financial Services Inc — 0.34%
  6. FMR LLC — 0.24%
Learn More about top institutional investors of Puma Biotechnology stock.

Which major investors are selling Puma Biotechnology stock?

Within the last quarter, PBYI stock was sold by these institutional investors:
  1. GSA Capital Partners LLP
  2. Geode Capital Management LLC
  3. XTX Topco Ltd
  4. Charles Schwab Investment Management Inc.
During the previous year, company insiders that have sold Puma Biotechnology company stock include:
  1. Alan H Auerbach (CEO)
  2. Maximo F Nougues (CFO)
  3. Jeffrey Jerome Ludwig (Insider)
  4. Alvin F Wong (Insider)
  5. Michael Patrick Miller (Director)
  6. Troy Edward Wilson (Director)
Learn More investors selling Puma Biotechnology stock.

Which major investors are buying Puma Biotechnology stock?

During the previous quarter, PBYI stock was bought by institutional investors including:
  1. Los Angeles Capital Management LLC
  2. Advantage Alpha Capital Partners LP
  3. State Street Corp
  4. BNP Paribas Financial Markets
  5. Barclays PLC
  6. Barclays PLC
  7. Virtu Financial LLC
  8. FMR LLC